Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07471295

Toric Performance And Constant Evaluation

Prospective Assessment of Constant Optimization and Visual Outcomes Following Monofocal Toric IOL Implantation

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
130 (estimated)
Sponsor
Carl Zeiss Meditec AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this investigation is to support safety and performance assessment of the investigational device with a focus on optimizing the IOL constants based on refractive outcomes.

Conditions

Interventions

TypeNameDescription
DEVICEMonofocal toric IOLThe device under investigation is a CE-approved monofocal bitoric, aspheric, aberration-correcting intraocular lens indicated for aphakia after surgical extraction of the cataractous natural lens and is also indicated for the correction of regular corneal astigmatism.

Timeline

Start date
2026-05-01
Primary completion
2028-02-28
Completion
2028-02-28
First posted
2026-03-13
Last updated
2026-03-13

Locations

6 sites across 4 countries: Czechia, Germany, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT07471295. Inclusion in this directory is not an endorsement.